Jesper Haaning

Project Vice President
Novo Nordisk A/S

Presentation(s):

• LB 01.2 - Concizumab Prophylaxis in Patients With Haemophilia A or B With Inhibitors: Efficacy and Safety Results From the Primary Analysis of the Phase 3 explorer7 Trial

  Sunday, July 10, 2022
  3:00 PM – 3:15 PM